
Novartis in US$465m deal with 3B Pharmaceuticals GmbH
Under the agreement, which foresees US$425m in milestones plus royalities on future sales for 3B Pharmaceuticals GmbH (3BP), Basel-based pharma...

Dualyx NV raises €40m in Series A financing
The Series A financing was co-led by Fountain Healthcare Partners, Forbion and Andera Partners and seed investors V-Bio Ventures, BGV, PMV, VIB,...

Dutch State to sell share capital of Intravacc BV
Two years after the establishment of the private company Intravacc BV (Bilthoven, The Netherlands), the sale of the former Netherlands Vaccine...

LSP Dementia Fund closes at €260m
Investors included the Alzheimer’s Association, the European Investment Fund EIF, several unnamed global pharmaceutical, and insurance companies,...

Ariceum Therapeutics extends Series A to €47.75m
The Series A financing was co-led by new investors Andera Partners and Earlybird Venture Capital. Existing investor Pureos Bioventures doubled its...

The innovative power of the chemical industry assembled
From cosmetics to medical treatments, from agriculture to the fabrics that make out our clothes – chemistry is ubiquitously needed in countless...

Adaptyv Biosytems launches protein engineering foundry
Machine learning algorithms and generative AI are upending traditional processes in life sciences and collapsing time frames in drug discovery and...